Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioTime has signed a licensing agreement with the Wisconsin Alumni Research Foundation to 173 patents and patent applications filed internationally relating to human embryonic stem cell technology created by James Thomson at the University of Wisconsin-Madison.
Subscribe to our email newsletter
Officials at the Wisconsin Alumni Research Foundation (WARF) noted that this licensing agreement with BioTime demonstrates that commercial interest in human embryonic stem cells remains strong. With this agreement, WARF now has completed 23 licensing agreements for stem cell technologies with 17 companies.
Michael West, BioTime’s CEO, said: “I am pleased to be able to work with WARF to commercialize our technology in the research market. The license of the WARF patents will allow us to manufacture and commercialize human embryonic stem cell-derived cell types and related products for scientists to use in research and in drug discovery.”